Sara Belloli Selected Research

Sara Belloli Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 01/2013
4	Neuroinflammatory Diseases 02/2023 - 04/2009
4	Disease Progression 01/2020 - 04/2009
3	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2008
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
1	Rare Diseases (Rare Disease) 01/2024
1	Encephalitis (Encephalitis, Rasmussen) 02/2023
1	Huntington Disease (Huntington's Disease) 02/2023
1	Body Weight (Weight, Body) 11/2022
1	Hypercholesterolemia 11/2022
1	Stroke (Strokes) 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Insulin Resistance 04/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2021
1	Glioma (Gliomas) 08/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Multiple Sclerosis 02/2018
1	Nervous System Diseases (Neurological Disorders) 02/2018
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Ischemia 01/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 12/2017
1	Hypoxia (Hypoxemia) 07/2013
1	Papilloma (Papillomatosis) 01/2013
1	Lung Injury 04/2012
1	Adenocarcinoma 08/2009
1	Prostatic Neoplasms (Prostate Cancer) 08/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2018
3	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 08/2013
3	LigandsIBA 02/2018 - 04/2009
2	Quinolinic AcidIBA 02/2023 - 01/2015
2	human ERBB2 proteinIBA 01/2021 - 01/2017
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2024
1	Probenecid (Benemid)FDA LinkGeneric 01/2024
1	Familial apoceruloplasmin deficiencyIBA 01/2024
1	ProteomeIBA 01/2024
1	Neuroprotective AgentsIBA 02/2023
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 02/2023
1	montelukast (Singulair)FDA Link 02/2023
1	EnzymesIBA 11/2022
1	VC701 compoundIBA 09/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	alpha2 Subunit Collagen Type IIBA 04/2021
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 04/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	IronIBA 01/2020
1	ChemokinesIBA 01/2020
1	CytokinesIBA 01/2020
1	SynucleinsIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	alovudineIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 12/2017
1	Temozolomide (Temodar)FDA LinkGeneric 12/2017
1	NanoconjugatesIBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Drug CarriersIBA 01/2017
1	CopperIBA 07/2013
1	AntibodiesIBA 07/2013
1	Carbonic Anhydrase IXIBA 07/2013
1	anthraceneIBA 01/2013
1	CarcinogensIBA 01/2013
1	AcidsIBA 04/2012
1	FluorineIBA 04/2012
1	Deoxyglucose (2 Deoxy D glucose)IBA 04/2012
1	Hormones (Hormone)IBA 08/2009
1	Lysergic Acid Diethylamide (LSD)IBA 04/2009
1	Estrogen ReceptorsIBA 02/2008

Therapy/Procedure

5	Therapeutics 01/2024 - 07/2013
1	Thrombectomy 01/2022
1	Precision Medicine 08/2020
1	Adjuvant Chemotherapy 01/2018
1	Anesthesia 01/2018
1	Resuscitation 01/2018
1	Hematopoietic Stem Cell Transplantation 04/2009